Real-life Surveillance Study of Patients With Chronic Hepatitis C Treated With PegIntron Injector and Rebetol (Study P04538)(COMPLETED)

NCT00727311 · clinicaltrials.gov ↗

COMPLETED

Status

2302

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C, Chronic
Hepatitis C

Interventions

BIOLOGICAL: PegIntron (peginterferon alfa-2b; SCH 54031) injector
DRUG: Rebetol (ribavirin; SCH 18908)

Sponsor

Merck Sharp & Dohme LLC